Femasys Inc
NASDAQ:FEMY
Femasys Inc
NASDAQ:FEMY
Price:
1.21 USD
-4.72%
Updated:
May 13, 2024
Femasys Inc
Income from Continuing Operations
|
Femasys Inc
Income from Continuing Operations Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Femasys Inc
NASDAQ:FEMY
|
Income from Continuing Operations
-$14.2m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Income from Continuing Operations
$1.3B
|
CAGR 3-Years
7%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
3%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Income from Continuing Operations
$1.8B
|
CAGR 3-Years
92%
|
CAGR 5-Years
0%
|
CAGR 10-Years
17%
|
|
|
Stryker Corp
NYSE:SYK
|
Income from Continuing Operations
$3.4B
|
CAGR 3-Years
34%
|
CAGR 5-Years
11%
|
CAGR 10-Years
16%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Income from Continuing Operations
$5.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
16%
|
CAGR 10-Years
13%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Income from Continuing Operations
$2B
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
14%
|
See Also
What is Femasys Inc's Income from Continuing Operations?
Income from Continuing Operations
-14.2m
USD
-14.2m
USD
Based on the financial report for Dec 31, 2023, Femasys Inc's Income from Continuing Operations amounts to -14.2m USD.
What is Femasys Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 3Y
-27%
-27%
Over the last year, the Income from Continuing Operations growth was -25%. The average annual Income from Continuing Operations growth rates for Femasys Inc have been -27% over the past three years .
You don't have any saved screeners yet
